CLOROX|DE ($CLX) is expected to release its quarterly earnings data on Monday, November 3rd after market close, per Finnhub. Analysts are expecting revenue of $1,413,839,581 and earnings of $0.79 per share.
You can see Quiver Quantitative's $CLX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLOROX|DE Insider Trading Activity
CLOROX|DE insiders have traded $CLX stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:
- ERIC H REYNOLDS (EVP - Chief Operating Officer) sold 15,041 shares for an estimated $1,861,847
- PIERRE R BREBER purchased 4,000 shares for an estimated $546,285
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLOROX|DE Hedge Fund Activity
We have seen 514 institutional investors add shares of CLOROX|DE stock to their portfolio, and 575 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. added 1,883,465 shares (+138.3%) to their portfolio in Q2 2025, for an estimated $226,147,642
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,684,594 shares (+250.2%) to their portfolio in Q2 2025, for an estimated $202,269,201
- VAN ECK ASSOCIATES CORP added 1,362,163 shares (+3854.7%) to their portfolio in Q2 2025, for an estimated $163,554,911
- BLACKROCK, INC. removed 1,342,815 shares (-11.3%) from their portfolio in Q2 2025, for an estimated $161,231,797
- TWO SIGMA INVESTMENTS, LP added 1,229,023 shares (+1722.4%) to their portfolio in Q2 2025, for an estimated $147,568,791
- MILLENNIUM MANAGEMENT LLC added 905,607 shares (+153.5%) to their portfolio in Q2 2025, for an estimated $108,736,232
- HOLOCENE ADVISORS, LP removed 863,437 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $103,672,880
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLOROX|DE Congressional Stock Trading
Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CLOROX|DE Analyst Ratings
Wall Street analysts have issued reports on $CLX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 10/01/2025
- Jefferies issued a "Buy" rating on 06/26/2025
To track analyst ratings and price targets for CLOROX|DE, check out Quiver Quantitative's $CLX forecast page.
CLOROX|DE Price Targets
Multiple analysts have issued price targets for $CLX recently. We have seen 8 analysts offer price targets for $CLX in the last 6 months, with a median target of $127.5.
Here are some recent targets:
- Andrea Teixeira from JP Morgan set a target price of $127.0 on 10/10/2025
- Filippo Falorni from Citigroup set a target price of $130.0 on 10/09/2025
- Anna Lizzul from B of A Securities set a target price of $125.0 on 10/08/2025
- Peter Grom from UBS set a target price of $128.0 on 10/08/2025
- Lauren Lieberman from Barclays set a target price of $112.0 on 10/01/2025
- Chris Carey from Wells Fargo set a target price of $125.0 on 09/25/2025
- Dara Mohsenian from Morgan Stanley set a target price of $137.0 on 08/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
